ArticleJournal of pediatric gastroenterology and nutrition2026

Vedolizumab for extraintestinal manifestations in pediatric inflammatory bowel disease: Results from the VedoKids study.

Giulia D'Arcangelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.